In Vitro Synergistic Effect of Lefamulin with Doxycycline, Rifampin, and Quinupristin/Dalfopristin Against Enterococci
2024

Lefamulin and Antibiotic Combinations Against Enterococci

Sample size: 66 publication 10 minutes Evidence: high

Author Information

Author(s): Min Yu-Hong, Kim Yong-ung, Park Min Chul

Primary Institution: Daegu Haany University and Inje University

Hypothesis

Can lefamulin combined with other antibiotics show synergistic effects against Enterococcus faecium and Enterococcus faecalis?

Conclusion

Lefamulin combined with doxycycline or rifampin shows strong synergistic effects against Enterococcus faecium and Enterococcus faecalis.

Supporting Evidence

  • 85.3% of E. faecium strains showed synergy with lefamulin and doxycycline.
  • 97.1% of E. faecium strains showed synergy with lefamulin and rifampin.
  • 94.4% of vancomycin-resistant E. faecium strains showed synergy with lefamulin and doxycycline.
  • 93.9% of E. faecalis strains showed synergy with lefamulin and doxycycline.

Takeaway

This study found that mixing a new antibiotic called lefamulin with other antibiotics can help fight certain tough bacteria that usually resist treatment.

Methodology

The study used checkerboard and time-kill assays to evaluate the synergistic effects of lefamulin with other antibiotics against clinical strains of Enterococcus.

Limitations

The study's results are based on in vitro tests and need clinical validation.

Participant Demographics

Clinical isolates of Enterococcus faecium and Enterococcus faecalis from hospitals in South Korea.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/microorganisms12122515

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication